Legacy Wealth Asset Management LLC Invests $253,000 in Electromed, Inc. (NYSE:ELMD)

Legacy Wealth Asset Management LLC acquired a new stake in shares of Electromed, Inc. (NYSE:ELMD) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 8,550 shares of the company’s stock, valued at approximately $253,000. Legacy Wealth Asset Management LLC owned approximately 0.10% of Electromed as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the stock. Renaissance Technologies LLC grew its holdings in shares of Electromed by 4.8% during the 2nd quarter. Renaissance Technologies LLC now owns 103,004 shares of the company’s stock valued at $1,548,000 after acquiring an additional 4,736 shares in the last quarter. Hunter Associates Investment Management LLC grew its stake in Electromed by 12.3% in the third quarter. Hunter Associates Investment Management LLC now owns 102,450 shares of the company’s stock valued at $2,199,000 after purchasing an additional 11,250 shares in the last quarter. Gabelli Funds LLC increased its position in Electromed by 7.8% in the 2nd quarter. Gabelli Funds LLC now owns 38,675 shares of the company’s stock worth $581,000 after purchasing an additional 2,808 shares during the last quarter. Pekin Hardy Strauss Inc. raised its stake in shares of Electromed by 9.9% during the 3rd quarter. Pekin Hardy Strauss Inc. now owns 38,185 shares of the company’s stock worth $820,000 after purchasing an additional 3,435 shares in the last quarter. Finally, State Street Corp lifted its holdings in shares of Electromed by 14.5% during the 3rd quarter. State Street Corp now owns 22,066 shares of the company’s stock valued at $474,000 after buying an additional 2,800 shares during the last quarter. Institutional investors and hedge funds own 40.82% of the company’s stock.

Insiders Place Their Bets

In other Electromed news, Director Andrew Summers sold 17,463 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $30.09, for a total transaction of $525,461.67. Following the completion of the sale, the director now directly owns 189,838 shares in the company, valued at $5,712,225.42. This represents a 8.42 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 14.00% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Electromed from a “strong-buy” rating to a “buy” rating in a report on Thursday, January 9th.

Electromed Trading Up 0.4 %

ELMD stock opened at $34.00 on Friday. The firm has a market cap of $287.64 million, a PE ratio of 47.22 and a beta of 0.31. Electromed, Inc. has a 1 year low of $9.90 and a 1 year high of $34.25. The company has a fifty day simple moving average of $29.57 and a 200 day simple moving average of $22.27.

Electromed (NYSE:ELMD) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.13. The company had revenue of $14.67 million during the quarter. Electromed had a return on equity of 15.32% and a net margin of 11.34%.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.